A detailed history of Geode Capital Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,798,666 shares of PTCT stock, worth $87.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,798,666
Previous 1,787,780 0.61%
Holding current value
$87.4 Million
Previous $54.7 Million 22.06%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.39 - $37.66 $330,825 - $409,966
10,886 Added 0.61%
1,798,666 $66.7 Million
Q2 2024

Aug 09, 2024

BUY
$24.69 - $40.12 $3.08 Million - $5 Million
124,712 Added 7.5%
1,787,780 $54.7 Million
Q1 2024

May 13, 2024

BUY
$24.15 - $31.95 $1.25 Million - $1.66 Million
51,843 Added 3.22%
1,663,068 $48.4 Million
Q4 2023

Feb 13, 2024

BUY
$18.07 - $29.37 $1.62 Million - $2.63 Million
89,396 Added 5.87%
1,611,225 $44.4 Million
Q3 2023

Nov 13, 2023

BUY
$22.41 - $41.99 $1.4 Million - $2.62 Million
62,289 Added 4.27%
1,521,829 $34.1 Million
Q2 2023

Aug 11, 2023

BUY
$40.4 - $59.1 $2.99 Million - $4.38 Million
74,130 Added 5.35%
1,459,540 $59.4 Million
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $2.24 Million - $2.87 Million
58,786 Added 4.43%
1,385,410 $67.1 Million
Q4 2022

Feb 13, 2023

BUY
$33.53 - $54.79 $1.59 Million - $2.6 Million
47,426 Added 3.71%
1,326,624 $50.6 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $2.27 Million - $2.93 Million
-54,321 Reduced 4.07%
1,279,198 $64.2 Million
Q2 2022

Aug 12, 2022

BUY
$25.6 - $45.23 $1.08 Million - $1.92 Million
42,380 Added 3.28%
1,333,519 $53.4 Million
Q1 2022

May 13, 2022

BUY
$33.33 - $44.6 $633,569 - $847,801
19,009 Added 1.49%
1,291,139 $48.2 Million
Q4 2021

Feb 11, 2022

SELL
$35.36 - $41.86 $229,698 - $271,922
-6,496 Reduced 0.51%
1,272,130 $50.7 Million
Q3 2021

Nov 12, 2021

BUY
$37.01 - $44.74 $417,731 - $504,980
11,287 Added 0.89%
1,278,626 $47.6 Million
Q2 2021

Aug 13, 2021

BUY
$37.95 - $49.37 $4.49 Million - $5.84 Million
118,239 Added 10.29%
1,267,339 $53.6 Million
Q1 2021

May 12, 2021

BUY
$46.8 - $68.92 $4.91 Million - $7.23 Million
104,952 Added 10.05%
1,149,100 $54.4 Million
Q4 2020

Feb 12, 2021

BUY
$47.96 - $67.64 $3.09 Million - $4.36 Million
64,473 Added 6.58%
1,044,148 $63.7 Million
Q3 2020

Nov 13, 2020

BUY
$45.41 - $57.07 $837,542 - $1.05 Million
18,444 Added 1.92%
979,675 $45.8 Million
Q2 2020

Aug 13, 2020

BUY
$42.56 - $54.98 $1.44 Million - $1.86 Million
33,785 Added 3.64%
961,231 $48.8 Million
Q1 2020

May 14, 2020

BUY
$32.37 - $59.36 $2.17 Million - $3.98 Million
67,097 Added 7.8%
927,446 $41.4 Million
Q4 2019

Feb 13, 2020

BUY
$32.22 - $50.07 $2.35 Million - $3.66 Million
73,080 Added 9.28%
860,349 $41.3 Million
Q3 2019

Nov 12, 2019

BUY
$33.82 - $48.17 $1.79 Million - $2.55 Million
52,852 Added 7.2%
787,269 $26.6 Million
Q2 2019

Aug 14, 2019

BUY
$35.42 - $45.0 $1.88 Million - $2.39 Million
53,069 Added 7.79%
734,417 $33 Million
Q1 2019

May 14, 2019

BUY
$28.09 - $39.49 $3.31 Million - $4.66 Million
117,942 Added 20.93%
681,348 $25.6 Million
Q4 2018

Feb 13, 2019

BUY
$29.83 - $46.51 $1.12 Million - $1.75 Million
37,593 Added 7.15%
563,406 $19.3 Million
Q3 2018

Nov 13, 2018

BUY
$33.9 - $47.77 $2.69 Million - $3.79 Million
79,294 Added 17.76%
525,813 $24.7 Million
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $2.09 Million - $3.89 Million
81,197 Added 22.23%
446,519 $15.1 Million
Q1 2018

May 15, 2018

BUY
$17.46 - $32.59 $876,666 - $1.64 Million
50,210 Added 15.93%
365,322 $9.89 Million
Q4 2017

Feb 13, 2018

SELL
$15.14 - $20.89 $725,100 - $1 Million
-47,893 Reduced 13.19%
315,112 $5.26 Million
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $1.2 Million - $1.55 Million
71,590 Added 24.57%
363,005 $7.26 Million
Q2 2017

Aug 14, 2017

BUY
N/A
291,415
291,415 $5.34 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.48B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.